Logo image of FRZA

FORZA X1 INC (FRZA) Stock Fundamental Analysis

NASDAQ:FRZA - Nasdaq - US34988N1046 - Common Stock - Currency: USD

0.2601  -0.02 (-8.09%)

After market: 0.262 +0 (+0.73%)

Fundamental Rating

1

FRZA gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 30 industry peers in the Leisure Products industry. FRZA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. FRZA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year FRZA has reported negative net income.
FRZA had a negative operating cash flow in the past year.
FRZA Yearly Net Income VS EBIT VS OCF VS FCFFRZA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 -2M -4M -6M

1.2 Ratios

The Return On Assets of FRZA (-49.00%) is worse than 81.25% of its industry peers.
With a Return On Equity value of -51.59%, FRZA is not doing good in the industry: 71.88% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -49%
ROE -51.59%
ROIC N/A
ROA(3y)-27.07%
ROA(5y)N/A
ROE(3y)-30.82%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FRZA Yearly ROA, ROE, ROICFRZA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 -10 -20 -30

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for FRZA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FRZA Yearly Profit, Operating, Gross MarginsFRZA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 -5K -10K -15K

More info and screens

4

2. Health

2.1 Basic Checks

FRZA does not have a ROIC to compare to the WACC, probably because it is not profitable.
FRZA has more shares outstanding than it did 1 year ago.
FRZA has a worse debt/assets ratio than last year.
FRZA Yearly Shares OutstandingFRZA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M
FRZA Yearly Total Debt VS Total AssetsFRZA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of 1.61, we must say that FRZA is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.61, FRZA is doing worse than 68.75% of the companies in the same industry.
FRZA has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of FRZA (0.01) is better than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 1.61
ROIC/WACCN/A
WACC8.35%
FRZA Yearly LT Debt VS Equity VS FCFFRZA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 5M -5M 10M 15M

2.3 Liquidity

A Current Ratio of 14.62 indicates that FRZA has no problem at all paying its short term obligations.
FRZA has a better Current ratio (14.62) than 100.00% of its industry peers.
A Quick Ratio of 14.15 indicates that FRZA has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 14.15, FRZA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 14.62
Quick Ratio 14.15
FRZA Yearly Current Assets VS Current LiabilitesFRZA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 28.83% over the past year.
EPS 1Y (TTM)28.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-38.25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y100%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FRZA Yearly Revenue VS EstimatesFRZA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2M 4M 6M 8M 10M
FRZA Yearly EPS VS EstimatesFRZA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 -0.1 -0.2 -0.3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for FRZA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FRZA Price Earnings VS Forward Price EarningsFRZA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FRZA Per share dataFRZA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

FRZA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FORZA X1 INC

NASDAQ:FRZA (10/9/2024, 8:00:00 PM)

After market: 0.262 +0 (+0.73%)

0.2601

-0.02 (-8.09%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)03-26 2024-03-26/bmo
Earnings (Next)N/A N/A
Inst Owners1.71%
Inst Owner Change-80.84%
Ins Owners0.16%
Ins Owner Change-1118.76%
Market Cap4.10M
Analysts82.86
Price Target5.1 (1860.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 106.31
P/FCF N/A
P/OCF N/A
P/B 0.33
P/tB 0.33
EV/EBITDA N/A
EPS(TTM)-0.41
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.52
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS0
BVpS0.79
TBVpS0.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -49%
ROE -51.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-27.07%
ROA(5y)N/A
ROE(3y)-30.82%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2408.72%
Cap/Sales 14095.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 14.62
Quick Ratio 14.15
Altman-Z 1.61
F-Score4
WACC8.35%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-38.25%
EPS Next Y100%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-74.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-22.79%
OCF growth 3YN/A
OCF growth 5YN/A